Haemato AG Stock
Price
Target price
€15.05
€15.05
0.330%
0.05
0.330%
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Haemato AG Stock
Haemato AG gained 0.330% compared to yesterday.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Haemato AG stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Haemato AG in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
S********** s********
?
G***** c******* t* c**********
Cons
?
B****
?
M***** P*******
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Haemato AG vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Haemato AG | 0.330% | 1.689% | -16.389% | -15.922% | -44.259% | -57.244% | - |
| MPH Health Care AG | 8.160% | 2.913% | -7.424% | 51.971% | 27.711% | -30.033% | -49.882% |
| Biotest AG ST | -0.480% | -0.957% | -2.358% | -2.358% | -2.358% | 45.775% | 68.980% |
| Biotest AG VZ | -0.690% | 0.000% | 9.542% | -5.592% | -7.419% | -1.712% | 30.159% |
News
EQS-Adhoc: HAEMATO AG: Termination of listing in the Open Market
EQS-Adhoc: HAEMATO AG: Termination of listing in the Open Market
EQS-News: HAEMATO AG publishes figures for the third quarter of 2023: Sales increase of around 13% compared to the same period of the previous year, strong increase in EBIT margin and significant increase in
EQS-News: HAEMATO AG publishes figures for the third quarter of 2023: Sales increase of around 13% compared to the same period of the previous year, strong increase in EBIT margin and significant increase in
EQS-Adhoc: Termination of the botulinum toxin project
EQS-Adhoc: Termination of the botulinum toxin project